RECRUITINGOBSERVATIONAL
In Vivo Real-time Detection of Circulating Melanoma Cells
About This Trial
The objective of this clinical trial is to determine whether a Photoacoustic flow cytometry (PAFC)-based prototype device can detect circulating tumor cells (CTCs) in the blood of melanoma patients in vivo, in real time, and do so at detection limits at least one order of magnitude below the detection limits of currently existing ex vivo methods.
Who May Be Eligible (Plain English)
Who May Qualify:
- Age 18 to 80 years
- Histological documented diagnosis of melanoma
- Signed willing to sign a consent form form approved by the University of Arkansas for Medical Sciences (UAMS) Institutional Review Board (IRB)
- Must be able to sit still for 90 minutes
Who Should NOT Join This Trial:
- Active infection
- Current and significant medical or surgical condition as determined by the Investigator
- Diagnosis or evidence of organic brain syndrome
- Pregnancy or breastfeeding
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Age 18 to 80 years
* Histological documented diagnosis of melanoma
* Signed informed consent form approved by the University of Arkansas for Medical Sciences (UAMS) Institutional Review Board (IRB)
* Must be able to sit still for 90 minutes
Exclusion Criteria:
* Active infection
* Current and significant medical or surgical condition as determined by the Investigator
* Diagnosis or evidence of organic brain syndrome
* Pregnancy or breastfeeding
Locations (1)
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States